UnitedHealth Helps Save the Dow With Q3 Earnings

Photo of Chris Lange
By Chris Lange Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
UnitedHealth Helps Save the Dow With Q3 Earnings

© Courtesy of UnitedHealth Group

When UnitedHealth Group Inc. (NYSE: UNH | UNH Price Prediction) reported its third-quarter financial results before the markets opened on Tuesday, the Minnesota-based health care giant said that it had $3.88 in earnings per share (EPS) and $60.4 billion in revenue. That compared with consensus estimates of $3.75 in EPS and $59.79 billion in revenue, as well as the $3.41 per share and $56.56 billion posted in the same period of last year.

During the latest quarter, total revenues grew $3.8 billion or 6.7% year over year, led by double-digit percentage revenue growth for Optum.

UnitedHealthcare grew to serve 415,000 more people with medical benefits over the past year, driven by growth in commercial and Medicare Advantage membership, and with greater focus on serving people with higher acuity needs. This led to revenue growth of 4.7% to $48.1 billion in the quarter. Third-quarter 2019 earnings from operations at UnitedHealthcare grew by 3.8%, driven by revenue growth and strong cost disciplines.

Optum revenues grew by 13.3% year over year to $28.8 billion, and earnings from operations advanced 16.1%.

Looking ahead to the full year, the company now expects to see EPS in the range of $14.90 to $15.00, up from its previous forecast of $14.70 to $14.90. Consensus estimates call for $14.83 in EPS and $242.07 billion in revenue for the year.

[nativounit]

David S. Wichmann, CEO of UnitedHealth, commented:

Optum and UnitedHealthcare are driving value for our customers, creating momentum to finish the year strongly and move into 2020 with an intense focus on accelerating the growth of our businesses by advancing quality, affordability and satisfaction for those we serve.

Shares of UnitedHealth traded up 6.6% Tuesday morning, at $235.12 in a 52-week range of $208.07 to $287.94. The consensus price target is $287.75.

The Dow Jones industrial average was up fractionally at about 26,936 on last look.

[recirclink id=585081]
[wallst_email_signup]

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618